Home/Pipeline/Second Product

Second Product

Not Specified

CommercialApproved (FDA & EU 2025)

Key Facts

Indication
Not Specified
Phase
Commercial
Status
Approved (FDA & EU 2025)
Company

About Insmed

Insmed is a patient-centric, global biopharma leader with a mission to deliver transformative therapies for serious and rare diseases. The company has achieved significant commercial and clinical milestones, including regulatory approvals and advanced late-stage pipelines, underpinned by a culture consistently recognized as a top employer. Its strategy hinges on deep patient collaboration, a synergistic technology platform spanning drug delivery and small molecules, and a disciplined focus on high-need pulmonary and rare disease markets.

View full company profile